Literature DB >> 14700405

Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.

Hilmar Wisplinghoff1, Oliver A Cornely, Susanne Moser, Ullrich Bethe, Hartmut Stützer, Bernd Salzberger, Gerd Fätkenheuer, Harald Seifert.   

Abstract

OBJECTIVE: To examine the clinical and epidemiologic features, excess length of stay, extra costs, and mortality attributable to bloodstream infection (BSI) in neutropenic patients with hematologic malignancies.
DESIGN: Prospective cohort and matched case-control study. PATIENTS: All adult neutropenic patients with hematologic malignancies admitted to Cologne University Hospital between May 1, 1997, and April 30, 1998, were prospectively observed. Case-patients were defined as patients with nosocomial BSI; control-patients were selected among patients without BSI.
RESULTS: During the study period, the BSI rate in neutropenic patients was 14.3 per 100 neutropenic episodes. Eighty-four case-patients were included. Matching was successful for 96% of the cohort; 81 matched pairs were studied. The mean total length of stay was significantly longer for patients with BSI than for control-patients (37 vs 29 days; P = .002). Extra costs attributable to the infection averaged 3,200 dollars (U.S.) per patient. The crude mortality rates of case-patients and control-patients were 16% and 4%, respectively (P = .013), with an attributable mortality of 12% (odds ratio, 11). Eighty-seven percent of patients met the criteria for sepsis according to the American College of Chest Physicians/Society of Critical Care Medicine. Severe sepsis or septic shock occurred in 13% of patients and was correlated with mortality (55% vs 10% in patients without severe sepsis or septic shock; P = .01).
CONCLUSIONS: Nosocomial BSI in neutropenic patients is significantly associated with an excess length of hospital stay, extra costs, and excess mortality. Severe sepsis and septic shock are closely correlated with an adverse outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14700405     DOI: 10.1086/502158

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  18 in total

1.  Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

Authors:  B J Liss; J J Vehreschild; O A Cornely; M Hallek; G Fätkenheuer; H Wisplinghoff; H Seifert; M J G T Vehreschild
Journal:  Infection       Date:  2012-06-05       Impact factor: 3.553

Review 2.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

3.  Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections.

Authors:  E Velasco; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S C Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

4.  Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).

Authors:  Salvatore Giacomo Morano; Roberto Latagliata; Corrado Girmenia; Fulvio Massaro; Paola Berneschi; Alfonso Guerriero; Massimo Giampaoletti; Arianna Sammarco; Giorgia Annechini; Angelo Fama; Alice Di Rocco; Antonio Chistolini; Alessandra Micozzi; Matteo Molica; Walter Barberi; Clara Minotti; Gregorio Antonio Brunetti; Massimo Breccia; Claudio Cartoni; Saveria Capria; Giovanni Rosa; Giuliana Alimena; Robin Foà
Journal:  Support Care Cancer       Date:  2015-04-26       Impact factor: 3.603

5.  Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.

Authors:  Leon J Worth; John F Seymour; Monica A Slavin
Journal:  Support Care Cancer       Date:  2008-12-19       Impact factor: 3.603

6.  Dynamical system analysis of Staphylococcus epidermidis bloodstream infection.

Authors:  Hangyul M Chung; Megan M Cartwright; David M Bortz; Trachette L Jackson; John G Younger
Journal:  Shock       Date:  2008-11       Impact factor: 3.454

7.  Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.

Authors:  Hossam M Ashour; Amany El-Sharif
Journal:  J Transl Med       Date:  2009-02-19       Impact factor: 5.531

8.  Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection.

Authors:  Marcela R Camargo; James Venturini; Fátima R Vilani-Moreno; Maria Sueli P Arruda
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

9.  Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study.

Authors:  Catherine Huoi; Philippe Vanhems; Marie-Christine Nicolle; Mauricette Michallet; Thomas Bénet
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Neutropenic patients and their infectious complications at a University Hospital.

Authors:  Stella Sala Soares Lima; Monique Sedlmaier França; Camila Cristina Gonçalves Godoi; Glaucia Helena Martinho; Lenize Adriana de Jesus; Roberta Maia de Castro Romanelli; Wanessa Trindade Clemente
Journal:  Rev Bras Hematol Hemoter       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.